Novel lenalidomide-based combinations for treatment of multiple myeloma
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference89 articles.
1. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008
2. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003;Kristinsson;Journal of Clinical Oncology,2007
3. Relapse/refractory myeloma patients: potential treatment guidelines;San Miguel;Journal of Clinical Oncology,2009
4. The potential of immunomodulatory drugs in the treatment of solid tumors;Dalgleish;Future Oncology,2010
5. Lenalidomide in multiple myeloma: current experimental and clinical data;Cives;European Journal of Haematology,2012
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lenalidomide use in multiple myeloma (Review);Molecular and Clinical Oncology;2023-11-28
2. Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma;Cancers;2019-12-19
3. Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs;Cardiovascular & Hematological Disorders-Drug Targets;2019-01-28
4. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography;European Journal of Radiology;2016-12
5. Preclinical and clinical evaluation of elotuzumab, a SLAMF7-targeted humanized monoclonal antibody in development for multiple myeloma;Expert Review of Hematology;2015-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3